Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

MHRA becomes founding member of HealthAI Global Regulatory Network

The network of health regulators will focus on the safe and effective use of AI in healthcare

- PMLiVE

J&J’s Darzalex recommended by CHMP to treat smouldering multiple myeloma

If approved, Darzalex would be the first therapy approved in the EU for SMM

- PMLiVE

New Alzheimer’s Treatments Are Driving a Shift in Earlier Detection and Clinician Education Engagement

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing clinical behavior.

Medscape Education

EU flag

EC approves argenx’s subcutaneous Vyvgart for rare autoimmune disease CIPD

The drug has been authorised as a monotherapy for adults with progressive or relapsing active cases

- PMLiVE

The value of Medscape Extend – redefining omnichannel engagement with physicians in Europe

By Liisa Caliendo

- PMLiVE

“Humanizing Healthcare, Humanizing Education: The Power of Patient Integration”

Victoria Harvey-Jones, PhD, Clinical Strategist (Oncology) and Worldwide Patient Integration Lead to Present at the 2025 Patient Centricity & Engagement Conference

Medscape Education

- PMLiVE

Petauri™ Further Expands Global Pricing and Market Access Capabilities With Key Leadership Hires

Rapidly growing pharmaceutical services platform announces the addition of accomplished executives to the organization’s global pricing and market access team.

Petauri Evidence

- PMLiVE

Webinar: Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

An expert-led discussion exploring the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).

Petauri Evidence

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Datroway granted FDA accelerated approval for lung cancer

Approximately 226,650 new cases of lung cancer will be diagnosed in the US this year

- PMLiVE

Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa

The company is planning to submit regulatory applications for the candidate by the end of the year

- PMLiVE

PMGroup and Visions4Health launch Excellence in Healthcare Partnerships Awards

The programme was unveiled at this year’s NHS ConfedExpo in Manchester

- PMLiVE

Innovation with intention: balancing scientific progress and patient-centricity in oncology

By Matt Wadyka

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links